APA (7th ed.) Citation

Stanley, T. L., Zanni, M. V., Johnsen, S., Rasheed, S., Makimura, H., Lee, H., . . . Grinspoon, S. K. (2011). TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome. The journal of clinical endocrinology and metabolism, 96(1), E146-E150. https://doi.org/10.1210/jc.2010-1170

Chicago Style (17th ed.) Citation

Stanley, Takara L., Markella V. Zanni, Stine Johnsen, Sarah Rasheed, Hideo Makimura, Hang Lee, Victor K. Khor, Rexford S. Ahima, and Steven K. Grinspoon. "TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome." The Journal of Clinical Endocrinology and Metabolism 96, no. 1 (2011): E146-E150. https://doi.org/10.1210/jc.2010-1170.

MLA (9th ed.) Citation

Stanley, Takara L., et al. "TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome." The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, 2011, pp. E146-E150, https://doi.org/10.1210/jc.2010-1170.